This company is no longer active
Tabula Rasa HealthCare Management
Management criteria checks 3/4
Tabula Rasa HealthCare's CEO is Brian Adams, appointed in Sep 2022, has a tenure of 1.17 years. total yearly compensation is $2.30M, comprised of 19.6% salary and 80.4% bonuses, including company stock and options. directly owns 1.55% of the company’s shares, worth €4.10M. The average tenure of the management team and the board of directors is 2.5 years and 5 years respectively.
Key information
Brian Adams
Chief executive officer
US$2.3m
Total compensation
CEO salary percentage | 19.6% |
CEO tenure | 1.2yrs |
CEO ownership | 1.5% |
Management average tenure | 2.5yrs |
Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2023 | n/a | n/a | -US$61m |
Mar 31 2023 | n/a | n/a | -US$64m |
Dec 31 2022 | US$2m | US$450k | -US$77m |
Sep 30 2022 | n/a | n/a | -US$72m |
Jun 30 2022 | n/a | n/a | -US$58m |
Mar 31 2022 | n/a | n/a | -US$59m |
Dec 31 2021 | US$2m | US$403k | -US$52m |
Sep 30 2021 | n/a | n/a | -US$70m |
Jun 30 2021 | n/a | n/a | -US$80m |
Mar 31 2021 | n/a | n/a | -US$80m |
Dec 31 2020 | US$2m | US$385k | -US$57m |
Sep 30 2020 | n/a | n/a | -US$57m |
Jun 30 2020 | n/a | n/a | -US$44m |
Mar 31 2020 | n/a | n/a | -US$36m |
Dec 31 2019 | US$3m | US$408k | -US$32m |
Sep 30 2019 | n/a | n/a | -US$36m |
Jun 30 2019 | n/a | n/a | -US$18m |
Mar 31 2019 | n/a | n/a | -US$40m |
Dec 31 2018 | US$2m | US$408k | -US$47m |
Sep 30 2018 | n/a | n/a | -US$26m |
Jun 30 2018 | n/a | n/a | -US$30m |
Mar 31 2018 | n/a | n/a | -US$3m |
Dec 31 2017 | US$882k | US$328k | US$13m |
Sep 30 2017 | n/a | n/a | -US$3m |
Jun 30 2017 | n/a | n/a | -US$8m |
Mar 31 2017 | n/a | n/a | -US$7m |
Dec 31 2016 | US$2m | US$278k | -US$3m |
Compensation vs Market: Brian's total compensation ($USD2.30M) is above average for companies of similar size in the German market ($USD603.52K).
Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.
CEO
Brian Adams (41 yo)
1.2yrs
Tenure
US$2,301,712
Compensation
Mr. Brian W. Adams serves as President at Tabula Rasa HealthCare, Inc since September 14, 2022. He served as Vice President of Finance at CareKinesis, Inc. since October 2011 until 2014. He had been Co-Pre...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 1.2yrs | US$2.30m | 1.55% € 4.1m | |
Chief Financial Officer | 1.8yrs | US$1.46m | 0.41% € 1.1m | |
COO & President of Pharmacy Services | 9.4yrs | US$1.86m | 1.2% € 3.2m | |
VP, Corporate Controller & Chief Accounting Officer | less than a year | no data | 0.037% € 97.9k | |
Chief Technology Officer | 3.3yrs | no data | no data | |
Chief Administrative Officer | 8.8yrs | no data | no data | |
Senior Vice President of Investor Relations & Corporate Development | 3.7yrs | no data | no data | |
Chief Legal Officer & Corporate Secretary | less than a year | no data | no data | |
Chief People Officer | 1.8yrs | no data | no data | |
Chief of Staff | less than a year | no data | no data | |
Chief of Staff | 5.5yrs | no data | no data | |
Senior Vice President of Healthcare Analytics | 5.5yrs | no data | no data |
2.5yrs
Average Tenure
55yo
Average Age
Experienced Management: 43T's management team is considered experienced (2.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | less than a year | US$2.30m | 1.55% € 4.1m | |
Independent Director | 1.2yrs | US$257.50k | 0.29% € 767.6k | |
Independent Director | 6.7yrs | US$235.53k | 0.41% € 1.1m | |
Member of Strategic Advisory Board | no data | no data | no data | |
Member of Strategic Advisory Board | no data | no data | no data | |
Member of Strategic Advisory Board | no data | no data | no data | |
Independent Board Chairman | 5.3yrs | US$257.78k | 0.52% € 1.4m | |
Independent Director | 6.3yrs | US$239.47k | 0.33% € 864.7k | |
Independent Director | 4.7yrs | US$229.67k | 0.33% € 871.6k | |
Independent Director | 5yrs | US$231.33k | 0.17% € 455.5k | |
Member of Strategic Advisory Board | no data | no data | no data | |
Member of Strategic Advisory Board | no data | no data | no data |
5.0yrs
Average Tenure
62.5yo
Average Age
Experienced Board: 43T's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/11/04 11:43 |
End of Day Share Price | 2023/11/02 00:00 |
Earnings | 2023/06/30 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tabula Rasa HealthCare, Inc. is covered by 16 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Vikram Kesavabhotla | Baird |
William Sutherland | Benchmark Company |
Steven Halper | Cantor Fitzgerald & Co. |